Wednesday, March 19, 2025 - ET (Eastern Time, GMT-05:00)
Join industry colleagues in a morning Fun Run or Walk! Participants will meet in the Hilton Penn's Landing lobby at 6:00AM, and run just about 2 miles along the Riverwalk. All levels welcome to join!
- Fiduciary responsibilities
- Ethics and compliance
- Technology and its impact on accounting
- Managing responsibilities and evolving duties
CPE credits available: 1.2
- Dalton Smart - Senior Vice President Finance, Global Controller, Merck
- Scott Godsoe - U.S. Controller, Takeda Pharmaceuticals
- Rakhi Kumar - Chief Accounting Officer, Roivant Sciences
- Matthew Busch - Chief Accounting Officer, Amgen
- Robert Decker - VP, Corporate Controller, Chief Accounting Officer, Johnson & Johnson
Participate in a conversational exchange amongst industry peers in a setting of organized roundtables led by senior level finance and accounting professionals. Dive into pressing matters, emerging accounting guideline implementations, and shared challenges amongst biotech and pharmaceutical professionals.
*Must pre-register on website for this session as space is limited capacity.
Update on Non-GAAP items:
- Business restructuring
- Acquisition-Related
- New non-GAAP categories companies
- Comment letters trends
FASB, Including Technical Updates:
- Segment reporting
- Disaggregation of the Income Statement
- Accounting for Software and Related Disclosure
- Environmental Credits
- Grant Accounting
- Derivative Refinements impacting R&D Arrangements
- Interim Reporting – Narrow Improvements
- Technical Update: Intangibles Research Project, KPI Project
ESG Update:
- CSRD Double Materiality
- EU Taxonomy Process
- Third Party Service Providers
Accounting & Reporting Benchmarking:
- Net Operating Cash Flow and Free Cash Flow Metric
- License Payments and Cash Flow Classification
- Capitalization of R&D Expense – US GAAP versus IFRS
Benchmark Topics:
- Talent Development and Retention in Finance
- Latest trends on GenAI’s impact on finance, including successful use cases in deploying AI
- Other disclosure reporting practices
CPE credits available: 2.4
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
- DISE
- Segment Reporting
- Environmental Credits
- Tax reporting change
- ensuring sufficient documentation
- Practical applications and use cases
CPE credits available: 0.8
- Thomas Cunningham - Assistant Controller, Merck
- Scott Doelger - Vice President, Financial Reporting and Accounting, Bristol-Myers Squibb
- Marc Siegel - Former FASB and SASB Board Member, .
- Process automation identification
- Integration components
- Optimizing resources
CPE credits available: 0.8
- Tyler Mead - Senior Manager, Financial Reporting and Internal Controls, Immuneering Corporation
- New items proposed by FASB- R&D derivatives
- Deal trends and considerations for partnership
CPE credits available: 0.8
- Scott Raichilson - VP, Transactional and Technical Accounting, Royalty Pharma
- Sean Godbout - Global Corporate Controller, Biogen
- Best practices and approaches to filling roles within organization
- Talent retainment
- Supporting licensed professionals in your organization
CPE credits available: 0.8
- Laura Klein - Director, Consolidations and Financial Reporting, Bristol-Myers Squibb
- Dalton Smart - Senior Vice President Finance, Global Controller, Merck
- Cybersecurity
- 3rd party controls
- Supporting documents
- IPE
- Continuous monitoring to minimize touchpoints
CPE credits available: 0.8
- Stefan van Duyvendijk - Accounting Operations Evangelist, FloQast
- Robert Auslander - Vice President, Head of Internal Audit, Bausch & Lomb
- Anna Simansky - VP Global Audit Services, Zimmer Biomet
- Sandra Addo - Vice President, Chief Audit Executive, Merck
- Tiffany Stokes - Chief Audit Officer, Integra LifeSciences
- Valuation model creation
- DCF mode
- Resources to ensure accuracy
- Methods for model improvement
CPE credits available: 0.8
- R.J. Forbes - Senior Director, Corporate Finance and Investment Banking, Eli Lilly & Company
- Collaborations, mergers, reverse mergers, M&A activity
- Shifting procedures to align with parent entity
- Collaboration amongst finance and accounting teams from both organizations
CPE credits available: 0.8
- Meagan Caldwell - Senior Director of Technical Accounting, Sumitomo Pharma America, Inc
- Jennifer Essig - VP of Finance, Deciphera Pharmaceuticals
- Brad Krause - Senior Director, Corporate Financial Reporting, Eli Lilly & Company
- Control and ownership of responsibilities
- Effective tracking for optimal output
CPE credits available: 0.8
- Justin Renz - Chief Financial Officer, Ardelyx
- Rohit Gupta - Director, Global Revenue Finance, Pfizer
This open forum allows for senior level executives to exchange ideas and best practices for driving internal and organizational success through efficiencies, technology, and new innovations.
*Informa Connect reserves the right to qualify participants for this Summit. Attendees must be a Director/Senior Director/VP with 10+ years' experience and currently employed by a life sciences manufacturer.
CPE credits available: 0.8
- Mallory Morales - Chief Accounting Officer, Treasurer, Immuneering Corporation
- Michael Clark - Corporate Controller, Legend Biotech